
George Ioannou
Director, Hepatology, VA Puget Sound Health Care System · University of Washington School of Medicine
Credentials: · · · ·
History
- 1999–2002
Gastroenterology
- 1996–1999
Internal Medicine
- 1992–1996
OXFORD UNIV, OXFORD
Research
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Journal of Hepatology · 2017 · 952 citations
Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease
PLoS ONE · 2011 · 471 citations
Journal of Hepatology · 2017 · First of 3 authors · Corresponding · 456 citations

45 papers

31 papers

30 papers

26 papers

24 papers · 14 as a fellow
- EV
23 papers

23 papers

21 papers · 6 as a fellow
Grants
- 2026–2030
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $272.4K · Seattle Inst for Biomedical/Clinical Res
- 2020–2027
Development and Validation of a Cirrhosis-Specific Surgical Risk Calculator (C-SuRC)
Department of Veterans Affairs · I01
Contact PI · Va Puget Sound Healthcare System
- 2021–2026
Liver Cancer Disparities in Alaska Native and American Indian People
National Cancer Institute · P20
Contact PI · $2.7M · University of Washington
- 2019–2023
National Institute of Diabetes and Digestive and Kidney Diseases · R21
Contact PI · $411K · University of Washington
Clinical trials
- 2022–2024
COVID-19 Observational Research Collaboratory
Principal investigator · Completed
VA Office of Research and Development
- 2022–2026
Liver Cancer Disparities in American Indian and Alaska Native Persons
Principal investigator · Unknown · Phase 2
University of Washington
- 2019–2023
Flicker App for Minimal Hepatic Encephalopathy
Principal investigator · Unknown
University of Washington
- 2023–2031
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Study chair · Recruiting
VA Office of Research and Development



